DoP further extends timeline to apply for support under PLI scheme for bulk drugs: Gireesh Babu, New Delhi Wednesday, July 9, 2025, 08:00 Hrs [IST] The Department of Pharmaceutica ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

In 1945, penicillin became available to the public and was no longer an exclusive medication for the military, consummating in the transformation of an allegedly failed experiment to a life-saving ...

This important study looks into the effect of exogenous CoA on the response of TLR4-activated macrophages. Specifically, CoA enhances the LPS response by examining metabolomics, 13C tracing, and ...